CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas is a research paper published in Magnetic Resonance Imaging (2023). On theSindex it has a DataRank of 0.500. It has been cited 10 times, with 8 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.141
From 5 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 8 citers.
National Institutes of Health
Grant: R37CA248077
National Institutes of Health
Grant: R01CA228188
National Institutes of Health
Grant: 1S10ODO21648
NICHD NIH HHS
Grant: P50 HD103538
NIH HHS
Grant: S10 OD021648
FWCI
1.70
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals